Australia’s CSL has announced plans to expand its US presence over the next five years, resulting in approximately $1.5 ...

Swiss generics and biosimilars company Sandoz has announced the launch of Tyruko (natalizumab-sztn) in the USA.

South Korean biosimilars developer Celltrion today announced that the European Commission (EC) has granted marketing ...

A major British initiative is set to repurpose used nuclear materials, converting them into a consistent supply for ...

Spanish plasma-based medicines producer Grifols today announced that the US Food and Drug Administration (FDA) has approved ...

South Korean clinical-stage biotech ABL Bio has entered license, research and collaboration agreement with US pharma major ...

Canadian firm Zymeworks, a biotech managing a portfolio of licensed healthcare assets while developing a diverse pipeline of ...

The US Food and Drug Administration today announced it has approved Danish biotech firm Genmab’s Epkinly (epcoritamab-bysp) ...

New government funding will help make the boldest ideas in UK life sciences a reality – from putting robots to work in ...

Roche today announced positive Phase III results from the lidERA Breast Cancer study evaluating investigational giredestrant ...

Shares of US clinical-stage biopharmaceutical company Nuvalent jumped more than 15% to $111.22 by midday yesterday, after it ...

A clinical‑stage biotech company headquartered in Antwerp, Belgium, developing organ‑restricted therapies for fibrotic ...